title: Response to chronic systolic heart failure, guideline-directed medical therapy, and systemic hypotension-less pressure but maybe more risk (does this clinical scenario need more discussion?).
authors.forename: Kumar
authors.initials: K
authors.lastname: Satya
authors.forename: Eyad
authors.initials: E
authors.lastname: Alhaj
authors.forename: Robert L
authors.initials: RL
authors.lastname: Berkowtiz
mesh_terms: D000959:Antihypertensive Agents / Q000009:adverse effects*; D001794:Blood Pressure / Q000187:drug effects; D002316:Cardiotonic Agents / Q000009:adverse effects*; D054143:Heart Failure, Systolic / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D007022:Hypotension / Q000139:chemically induced* / Q000503:physiopathology; D017410:Practice Guidelines as Topic; D011379:Prognosis; D012307:Risk Factors
chemical_list: D000959:Antihypertensive Agents; D002316:Cardiotonic Agents